Modeling the binding modes of stilbene analogs to cyclooxygenase-2: a molecular docking study

被引:0
|
作者
Souhila Bouaziz-Terrachet
Amel Toumi-Maouche
Boubekeur Maouche
Safia Taïri-Kellou
机构
[1] Laboratoire de Physico-Chimie Théorique et Chimie Informatique,
[2] Faculté de Chimie,undefined
来源
关键词
Cyclooxygenase-2; COX-2; Molecular docking; AutoDock; Stilbenes; NSAIDs; Hydrophobic interactions;
D O I
暂无
中图分类号
学科分类号
摘要
Stilbene analogs are a new class of anti-inflammatory compounds that effectively inhibit COX-2, which is the major target in the treatment of inflammation and pain. In this study, docking simulations were conducted using AutoDock 4 software that focused on the binding of this class of compounds to COX-2 protein. Our aim was to better understand the structural and chemical features responsible for the recognition mechanism of these compounds, and to explore their binding modes of interaction at the active site by comparing them with COX-2 co-crystallized with SC-558. The docking results allowed us to provide a plausible explanation for the different binding affinities observed experimentally. These results show that important conserved residues, in particular Arg513, Phe518, Trp387, Leu352, Leu531 and Arg120, could be essential for the binding of the ligands to COX-2 protein. The quality of the docking model was estimated based on the binding energies of the studied compounds. A good correlation was obtained between experimental logAr values and the predicted binding energies of the studied compounds.
引用
收藏
页码:1919 / 1929
页数:10
相关论文
共 50 条
  • [1] Modeling the binding modes of stilbene analogs to cyclooxygenase-2: a molecular docking study
    Bouaziz-Terrachet, Souhila
    Toumi-Maouche, Amel
    Maouche, Boubekeur
    Tairi-Kellou, Safia
    JOURNAL OF MOLECULAR MODELING, 2010, 16 (12) : 1919 - 1929
  • [2] MOLECULAR DOCKING STUDY OF IBUPROFEN DERIVATIVES AS SELECTIVE INHIBITORS OF CYCLOOXYGENASE-2
    Chebrolu, A.
    Madhavan, S.
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2020, 11 (12): : 6526 - 6531
  • [3] Molecular Modeling of the Interactions between Carborane-Containing Analogs of Indomethacin and Cyclooxygenase-2
    Sarosi, Menyhart-Botond
    Neumann, Wilma
    Lybrand, Terry P.
    Hey-Hawkins, Evamarie
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2017, 57 (08) : 2056 - 2067
  • [4] Biological activity evaluation and molecular docking study of chromone derivatives as cyclooxygenase-2 inhibitors
    Chirattikan Maicheen
    Narumol Phosrithong
    Jiraporn Ungwitayatorn
    Medicinal Chemistry Research, 2017, 26 : 662 - 671
  • [5] Biological activity evaluation and molecular docking study of chromone derivatives as cyclooxygenase-2 inhibitors
    Maicheen, Chirattikan
    Phosrithong, Narumol
    Ungwitayatorn, Jiraporn
    MEDICINAL CHEMISTRY RESEARCH, 2017, 26 (03) : 662 - 671
  • [6] Molecular docking study and molecular dynamic simulation of human cyclooxygenase-2 (COX-2) with selected eutypoids
    Taidi, Loubna
    Maurady, Amal
    Britel, Mohammed Reda
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2022, 40 (03): : 1189 - 1204
  • [7] Molecular Docking Studies of Novel Palmitoyl-ligands for Cyclooxygenase-2
    Bhagavat, Raghu
    Saqib, Asma
    Karigar, Chandrakant
    CHEMICAL BIOLOGY & DRUG DESIGN, 2012, 79 (06) : 1043 - 1048
  • [8] Fluorocurcumins as Cyclooxygenase-2 Inhibitor: Molecular Docking, Pharmacokinetics and Tissue Distribution in Mice
    Padhye, Subhash
    Banerjee, Sanjeev
    Chavan, Deepak
    Pandye, Shubhangini
    Swamy, K. Venkateswara
    Ali, Shadan
    Li, Jing
    Dou, Q. Ping
    Sarkar, Fazlul H.
    PHARMACEUTICAL RESEARCH, 2009, 26 (11) : 2438 - 2445
  • [9] Molecular modeling of the interaction of the dihydroquercetin and its metabolites with cyclooxygenase-2
    Terekhov, R. P.
    Selivanova, I. A.
    BYULLETEN SIBIRSKOY MEDITSINY, 2019, 18 (03): : 101 - 106
  • [10] Fluorocurcumins as Cyclooxygenase-2 Inhibitor: Molecular Docking, Pharmacokinetics and Tissue Distribution in Mice
    Subhash Padhye
    Sanjeev Banerjee
    Deepak Chavan
    Shubhangini Pandye
    K.Venkateswara Swamy
    Shadan Ali
    Jing Li
    Q. Ping Dou
    Fazlul H. Sarkar
    Pharmaceutical Research, 2009, 26 : 2438 - 2445